Quick Takeaways
- Wei-Wu He filed SCHEDULE 13D/A for CASI Pharmaceuticals, Inc. Ordinary Shares (CASI).
- Disclosed ownership: 35%.
- Date of event: 27 Jan 2026.
Quoteable Key Fact
"Wei-Wu He disclosed 35% ownership in CASI Pharmaceuticals, Inc. Ordinary Shares (CASI) on 27 Jan 2026."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| WEI-WU HE, Ph.D. | 35% | 8,965,535 | 2,130,550 | 6,834,985 | /s/ Wei-Wu He, Ph.D. | Wei-Wu He, Ph.D. | 0001542073 |
| HUIYING MEMORIAL FOUNDATION | 3.1% | 637,644 | 0 | 637,644 | /s/ Wei-Wu He, Ph.D. | Wei-Wu He, Ph.D./President | |
| EMERGING TECHNOLOGY PARTNERS, LLC | 5.3% | 1,097,341 | 0 | 1,097,341 | /s/ Wei-Wu He, Ph.D. | Wei-Wu He, Ph.D./ Managing Member | |
| ETP Global Fund L.P. | 3.7% | 753,234 | 0 | 753,234 | EMERGING TECHNOLOGY PARTNERS, LLC | General Partner | |
| ETP BIOHEALTH III FUND, L.P. | 1.5% | 300,000 | 0 | 300,000 | EMERGING TECHNOLOGY PARTNERS, LLC | General Partner | |
| HE Family GRAT | 0.5% | 100,000 | 0 | 100,000 | /s/ Wei-Wu He, Ph.D. | Wei-Wu He, Ph.D./Trustee | |
| ETP Global Fund III L.P. | 20% | 5,000,000 | 0 | 5,000,000 | /s/ Wei-Wu He, Ph.D. | Wei-Wu He, Ph.D./ Managing Member |